recently became the first anti-emetic ODF to be approved in Japan. TAHO’s proprietary transepithelial delivery system (TDS) platform has been designed to deliver drug compounds directly into the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback